Back to Actions

Bill History in the Congressional Record

Page numbers for legislative actions on this bill link to the Congressional Record. Learn more about the History of Bills and Resolutions.


From the Congressional Record, Volume 161 (2015)









H.R. 3537 — A bill to amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, and for other purposes; to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

By Mr. DENT (for himself, Mr. Himes, Mr. Meehan, Mr. Dold, Mr. Tiberi, Mr. Costello of Pennsylvania, Mr. Hanna, Mr. Thompson of Pennsylvania, Mr. Rogers of Kentucky, Mr. Murphy of Pennsylvania, Mr. Barletta, Ms. Norton, Mr. Lance, Mrs. Comstock, Mr. Katko, Ms. Ros-Lehtinen, and Mr. Jolly), H6136 [17SE]
Cosponsors added, H6229 [24SE], H6706 [29SE], H7091 [21OC], H7139 [22OC], H8282 [17NO]



From the Congressional Record, Volume 162 (2016)









H.R. 3537 — A bill to amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, and for other purposes; to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Cosponsors added, H281 [11JA], H592 [4FE], H5525 [15SE]
Reported with amendments from the Committee on Energy and Commerce (H. Rept. 114–787, part 1), H5912 [26SE]
Debated, H5871 [26SE]
Text, H5871 [26SE]
Rules suspended. Passed House amended, H5893 [26SE]
Title amended, H5893 [26SE]
Committee on the Judiciary discharged, H5912 [26SE]
Message from the House, S6137 [27SE]
Read the first and second times, S6137 [27SE]
Referred to the Committee on the Judiciary, S6137 [27SE]